Netherlands· NL-f12f21f9f758

Briviact 10 mg/ml, oplossing voor injectie

A brivaracetam product containing brivaracetam, registered in Netherlands by UCB Pharma S.A.. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX23

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about brivaracetamAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Brivaracetam is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX23 (brivaracetam), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search brivaracetam products by name

Brivaracetam · ATC N03AX23

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of brivaracetam costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $2.61 in France to $22.97 in Switzerland — a ×8.8 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Brivaracetam · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

CH Switzerland$22.97
IT Italy$3.99
FR France$2.61

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BRIVARACETAM
Manufacturer: UCB Pharma S.A.
Country: Netherlands (NL)
ATC code: N03AX23
ATC class: Brivaracetam
Defined daily dose: 0.1 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/15/1073

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

91 interactions on record for brivaracetam.

Graded by severity as the source publishes them — 63 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check brivaracetam against other medicines How interaction checks work

Brivaracetam · interactions on record

91 records

63 moderate
28 minor

Most severe, free to view

MetoclopramideA03FA01moderate
ThiethylperazinA04AB03moderate
DiphenhydraminA04AB05moderate
DronabinolA04AD10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Brivaracetam in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All brivaracetam products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Abavalex, Brivaracetam Genericon
Belgium · Brivaracetam Teva
Bulgaria · Abavalex
Cyprus · Brivaracetam Accord
Czechia · Abavalex, Breluncol
Germany · Abavalex, Brivaracetam 1 A Pharma
Denmark · Abavalex, Brivaracetam Cipla
Spain · Brivaracetam Cinfa, Brivaracetam Combix
Finland · Brabela, Brivaracetam Desitin
France · Brivaracetam Biogaran, Brivaracetam La Colina
United Kingdom (Northern Ireland) · Brivaracetam Alissa, Brivaracetam Altair
Greece · Brivaracetam Anabiosis, Brivaracetam Anfarm
Croatia · Brivaracetam Accord, Brytyn
Hungary · Abavalex, Breluncol
Ireland · Brivaracetam Clonmel
Iceland · Brivaracetam, Brivaracetam Stada
Italy · Brileps, Brivaracetam Amarox
Liechtenstein · Briviact
Malta · Brivaracetam Anfarm, Brivaracetam Clonmel
Norway · Brivaracetam Desitin, Brivaracetam Glenmark
Poland · Abavalex, Brabela
Portugal · Brabela, Brivaracetam Anfarm
Romania · Abavalex, Breluncol
Sweden · Abavalex, Brivaracetam Amarox
Slovenia · Clizay
Slovakia · Abavalex, Breluncol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c4b30eca-967d-428d-aa3c-e628f055a46d
GET /v1/drugs/c4b30eca-967d-428d-aa3c-e628f055a46d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/briviact-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Brivaracetam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp116763",
  "excipients": [
    "AZIJNZUUR (E 260)",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "BRIVARACETAM"
  ],
  "leaflet_url": null,
  "authorised_at": "2016/01/14",
  "procedure_number": "EMEA/H/C/003898",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/15/1073",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about brivaracetam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console